Altimmune, Inc. (LON:0A4C)
5.39
-0.48 (-8.10%)
At close: Feb 3, 2026
Altimmune Revenue
Altimmune had revenue of $5.00K USD in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $20.00K, down -61.54% year-over-year. In the year 2024, Altimmune had annual revenue of $20.00K, down -95.31%.
Revenue
$20.00K
Revenue Growth
-61.54%
P/S Ratio
28,561.27
Revenue / Employee
$338.98
Employees
59
Market Cap
424.96M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20.00K | -406.00K | -95.31% |
| Dec 31, 2023 | 426.00K | 494.00K | - |
| Dec 31, 2022 | -68.00K | -4.48M | - |
| Dec 31, 2021 | 4.41M | -3.78M | -46.12% |
| Dec 31, 2020 | 8.19M | 2.38M | 41.09% |
| Dec 31, 2019 | 5.80M | -4.53M | -43.85% |
| Dec 31, 2018 | 10.33M | -407.15K | -3.79% |
| Dec 31, 2017 | 10.74M | 7.50M | 231.82% |
| Dec 31, 2016 | 3.24M | -7.40M | -69.59% |
| Dec 31, 2015 | 10.64M | 450.46K | 4.42% |
| Dec 31, 2014 | 10.19M | -7.72M | -43.11% |
| Dec 31, 2013 | 17.91M | -7.26M | -28.85% |
| Dec 31, 2012 | 25.18M | 909.61K | 3.75% |
| Dec 31, 2011 | 24.27M | 3.27M | 15.59% |
| Dec 31, 2010 | 20.99M | -6.56M | -23.80% |
| Dec 31, 2009 | 27.55M | -5.36M | -16.29% |
| Dec 31, 2008 | 32.91M | 18.27M | 124.75% |
| Dec 31, 2007 | 14.64M | 12.98M | 780.39% |
| Dec 31, 2006 | 1.66M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Capita | 2.34B |
| C&C Group | 1.41B |
| The Rank Group | 813.60M |
| Ferrexpo | 611.17M |
| Crest Nicholson Holdings | 610.80M |
| Hollywood Bowl Group | 250.66M |
| NCC Group | 238.90M |
| Gulf Keystone Petroleum | 119.09M |